OMER Q4 2023 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$835M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$205,000

Operating Income

-$40M

Net Income

-$9M

EPS (Diluted)

$-0.15

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$35M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$378M

Total Liabilities

$403M

Stockholders' Equity

-$25M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$205,000	$0	—
Operating Income	-$40M	-$40M	+0.9%
Net Income	-$9M	$129M	-107.0%